(Q79897713)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17344883%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Toll-free vaccines? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17344883%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Arthur M Krieg

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17344883%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17344883%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17344883%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17344883%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17344883%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

303-305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17344883%20AND%20SRC:MED&resulttype=core&format=json

Proteome survey reveals modularity of the yeast cell machinery

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNBT0307-303

7 January 2021

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity

1 reference

https://api.crossref.org/works/10.1038%2FNBT0307-303

7 January 2021

Control of B-cell responses by Toll-like receptors

1 reference

https://api.crossref.org/works/10.1038%2FNBT0307-303

7 January 2021

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

1 reference

https://api.crossref.org/works/10.1038%2FNBT0307-303

7 January 2021

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

1 reference

https://api.crossref.org/works/10.1038%2FNBT0307-303

7 January 2021

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

1 reference

https://api.crossref.org/works/10.1038%2FNBT0307-303

7 January 2021

CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0307-303

7 January 2021

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine

1 reference

https://api.crossref.org/works/10.1038%2FNBT0307-303

7 January 2021

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0307-303

7 January 2021

CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques

1 reference

https://api.crossref.org/works/10.1038%2FNBT0307-303

7 January 2021

TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity

1 reference

https://api.crossref.org/works/10.1038%2FNBT0307-303

7 January 2021

Identifiers

DOI

10.1038/NBT0307-303

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17344883%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference